117 related articles for article (PubMed ID: 3969374)
1. Grading of prostatic cancer (I): An analysis of the prognostic significance of single characteristics.
Schroeder FH; Blom JH; Hop WC; Mostofi FK
Prostate; 1985; 6(1):81-100. PubMed ID: 3969374
[TBL] [Abstract][Full Text] [Related]
2. Grading of prostatic cancer: II. The prognostic significance of the presence of multiple architectural patterns.
Schroeder FH; Blom JH; Hop WC; Mostofi FK
Prostate; 1985; 6(4):403-15. PubMed ID: 4088953
[TBL] [Abstract][Full Text] [Related]
3. Morphometrically estimated variation in nuclear size. A useful tool in grading prostatic cancer.
Blom JH; Ten Kate FJ; Schroeder FH; van der Heul RO
Urol Res; 1990; 18(2):93-9. PubMed ID: 2187298
[TBL] [Abstract][Full Text] [Related]
4. Grading of prostatic cancer: III. Multivariate analysis of prognostic parameters.
Schroeder FH; Hop WC; Blom JH; Mostofi FK
Prostate; 1985; 7(1):13-20. PubMed ID: 4080650
[TBL] [Abstract][Full Text] [Related]
5. Histological evaluation of prostatic cancer. (II): Reproducibility of a histological grading system.
Svanholm H; Starklint H; Barlebo H; Olsen S
APMIS; 1990 Mar; 98(3):229-36. PubMed ID: 2317346
[TBL] [Abstract][Full Text] [Related]
6. Combined histologic grading of prostatic carcinoma.
Böcking A; Kiehn J; Heinzel-Wach M
Cancer; 1982 Jul; 50(2):288-94. PubMed ID: 7083133
[TBL] [Abstract][Full Text] [Related]
7. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
[TBL] [Abstract][Full Text] [Related]
8. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR
Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085
[TBL] [Abstract][Full Text] [Related]
9. Histopathology of localized prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
Murphy GP; Busch C; Abrahamsson PA; Epstein JI; McNeal JE; Miller GJ; Mostofi FK; Nagle RB; Nordling S; Parkinson C
Scand J Urol Nephrol Suppl; 1994; 162():7-42; discussion 115-27. PubMed ID: 7817162
[TBL] [Abstract][Full Text] [Related]
10. Significance and outcome of nuclear anaplasia and mitotic index in prostatic adenocarcinomas.
Kır G; Sarbay BC; Gumus E
Urol Oncol; 2016 Oct; 34(10):430.e9-430.e16. PubMed ID: 27264167
[TBL] [Abstract][Full Text] [Related]
11. The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate Cancer.
Helpap B; Ringli D; Tonhauser J; Poser I; Breul J; Gevensleben H; Seifert HH
Pathol Oncol Res; 2016 Apr; 22(2):349-56. PubMed ID: 26563277
[TBL] [Abstract][Full Text] [Related]
12. High and low risk prostate carcinoma determined by histologic grade and proliferative activity.
Chiusa L; Galliano D; Formiconi A; Di Primio O; Pich A
Cancer; 1997 May; 79(10):1956-63. PubMed ID: 9149023
[TBL] [Abstract][Full Text] [Related]
13. Histologic grading of prostatic carcinoma.
Böcking A; Sinagowitz E
Pathol Res Pract; 1980; 168(1-3):115-25. PubMed ID: 7433250
[TBL] [Abstract][Full Text] [Related]
14. Do we truly see what we think we see? The role of cognitive bias in pathological interpretation.
Fandel TM; Pfnür M; Schäfer SC; Bacchetti P; Mast FW; Corinth C; Ansorge M; Melchior SW; Thüroff JW; Kirkpatrick CJ; Lehr HA
J Pathol; 2008 Oct; 216(2):193-200. PubMed ID: 18683853
[TBL] [Abstract][Full Text] [Related]
15. Stereologically estimated mean nuclear volume of prostatic cancer is a reliable prognostic parameter.
Arima K; Sugimura Y; Hioki T; Yamashita A; Kawamura J
Br J Cancer; 1997; 76(2):234-7. PubMed ID: 9231924
[TBL] [Abstract][Full Text] [Related]
16. [Results of karyometry of acinar adenocarcinoma of the prostate].
Taranenko AV; Dvornichenko VV; Batoroev IuK
Arkh Patol; 2012; 74(5):41-3. PubMed ID: 23342659
[TBL] [Abstract][Full Text] [Related]
17. Adenocarcinoma of the prostate with atrophic features.
Cina SJ; Epstein JI
Am J Surg Pathol; 1997 Mar; 21(3):289-95. PubMed ID: 9060598
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy.
Choy B; Pearce SM; Anderson BB; Shalhav AL; Zagaja G; Eggener SE; Paner GP
Am J Surg Pathol; 2016 Oct; 40(10):1400-6. PubMed ID: 27379821
[TBL] [Abstract][Full Text] [Related]
19. Prognostic criteria in patients with prostate cancer: Gleason score versus volume-weighted mean nuclear volume.
Fujikawa K; Sasaki M; Arai Y; Yamabe H; Ogawa O; Yoshida O
Clin Cancer Res; 1997 Apr; 3(4):613-8. PubMed ID: 9815728
[TBL] [Abstract][Full Text] [Related]
20. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
Zhao J; Epstein JI
Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
